Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop

Neural Regeneration Research

Volumn 10, Issue 6, 2015, Pages 925-931

  Shen, Ling Ling ^a   Jiang, Ming Liang ^a,b   Liu, Si Si ^a,b   Cai, Min Chun ^a   Hong, Zhong Qiu ^a   Lin, Li Qing ^a,b   Xing, Yan Yan ^a,b   Chen, Gui Lin ^a,b   Pan, Rui ^a   Yang, Li Juan ^a,b   Xu, Ying ^b   Dong, Jun ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Ca2+; Curcumin; Excitatory postsynaptic potential; HIV 1 gp120 V3 loop; HIV associated neurocognitive disorders; Long term potentiation; Nerve regeneration; Neural regeneration; Neurons; NSFC grants; Output input curve; Paired pulse facilitation; Plasticity; Synaptosome

Indexed keywords

CALCIUM ION; CURCUMIN; FURA 2; GLYCOPROTEIN GP 120; NIMODIPINE; VIRUS SPIKE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA1 REGION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERM POTENTIATION; MALE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; RAT; SYNAPTIC PLASTICITY IMPAIRMENT; SYNAPTIC TRANSMISSION;

EID: 84934768150     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.158358     Document Type: Article

References (43)

1. Adams MA, Ferraro FR (1997) Acquired immunodeficiency syndromedementia complex. J Clin Psychol 53:767-778
2. Albright A, Soldan S, González-Scarano F (2003) Pathogenesis of humanimmunodeficiency virus-induced neurological disease. J Neurovirol9:222-227
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, et al. (2007) Updated research nosologyfor HIV-associated neurocognitive disorders. Neurology 69:1789-1799
4. Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ (1994) Motor analysis predicts progression in HIV-associatedbrain disease. J Neurol Sci 123:180-185
5. Atluri VS, Pilakka-Kanthikeel S, Samikkannu T, Sagar V, Kurapati KR, Saxena SK, Yndart A, Raymond A, Ding H, Hernandez O, Nair MP (2014) Vorinostat positively regulates synaptic plasticity genes expressionand spine density in HIV infected neurons: role of nicotinein progression of HIV-associated neurocognitive disorder. Mol Brain 7: 37
6. Bachis A, Aden SA, Nosheny RL, Andrews PM, Mocchetti I (2006) Axonaltransport of human immunodeficiency virus type 1 envelopeprotein glycoprotein 120 is found in association with neuronal apoptosis. J Neurosci 26:6771-6780
7. Bagashev A, Mukerjee R, Santerre M, Del Carpio-Cano FE, Shrestha J, Wang Y, He JJ, Sawaya BE (2014) Involvement of miR-196a in HIV-associated neurocognitive disorders. Apoptosis 19:1202-1214
8. Barks JDE, Liu XH, Sun R, Silverstein FS (1997) gp120, a human immunodeficiencyvirus-1 coat protein, augments excitotoxic hippocampalinjury in perinatal rats. Neuroscience 76:397-409
9. Borjabad A, Volsky DJ (2012) Common transcriptional signatures inbrain tissue from patients with HIV-associated neurocognitive disorders,Alzheimer’s disease, and Multiple Sclerosis. J NeuroimmunePharmacol 7:914-926
10. Cashman JR, Ghirmai S, Abel KJ, Fiala M (2008) Immune defects inAlzheimer’s disease: new medications development. BMC Neurosci 9 Suppl 2:S13
11. Deng QY, Huang T, Tang HM, Zhong XM, Xia SJ, Wei XC, Dong J (2011)Curcumin protects against interleukin-6-induced rapid Ca2+ influxin rat hippocampal neurons. Neural Regen Res 6:1850-1854
12. Dong J, Lu DX, Pan R, Tang HM (2008) Effect and mechanism of curcuminon learning and memory dysfunction induced by gp120 inrats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24:328-331
13. Fields J, Dumaop W, Adame A, Ellis R, Letendre S, Grant I, Masliah E (2013) Alterations in the levels of vesicular trafficking proteinsinvolved in HIV replication in the brains and CSF of patients withHIV-associated neurocognitive disorders. J Neuroimmune Pharmacol8:1197-1209
14. Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH, Soukup VM (2012) Prefrontal dopaminergic and enkephalinergicsynaptic accommodation in HIV-associated neurocognitivedisorders and encephalitis. J Neuroimmune Pharmacol 7:686-700
15. Ghafouri M, Amini S, Khalili K, Sawaya BE (2006) HIV-1 associateddementia: symptoms and causes. Retrovirology 3:28
16. Ghiara JB, Stura EA, Stanfield RL, Profy AT, Wilson IA (1994) Crystalstructure of the principal neutralization site of HIV-1. Science 264:82-85
17. Gong Z, Yang LJ, Tang HM, Pan R, Xie S, Guo LY, Wang JB, Deng QY, Xiong GY, Xing YY, Dong J (2012) Protective effects of curcuminagainst human immunodeficiency virus 1 gp120 V3 loop-inducedneuronal injury in rats. Neural Regen Res 7:171-175
18. Guo L, Xing Y, Pan R, Jiang M, Gong Z, Lin L, Wang J, Xiong G, Dong J (2013) Curcumin protects microglia and primary rat cortical neuronsagainst HIV-1 gp120-mediated inflammation and apoptosis.PLoS One 8:e70565
19. He LF, Chen HJ, Qian LH, Chen GY, Buzby JS (2010) Curcumin protectspre-oligodendrocytes from activated microglia in vitro and invivo. Brain Res 1339:60-69
20. Hult B, Chana G, Masliah E, Everall I (2008) Neurobiology of HIV. IntRev Psychiatry 20:3-13
21. Kaul M, Lipton S (2006) Mechanisms of neuroimmunity and neurodegenerationassociated with HIV-1 infection and AIDS. J NeuroimmunePharmacol 1:138-151
22. Koutsilieri E, Scheller C, Sopper S, ter Meulen V, Riederer P (2002) Thepathogenesis of HIV-induced dementia. Mech Ageing Dev 123:1047-1053
23. Li Y, Wang PW (2009) Neuroprotective effects of curcumin. ZhongguoZhongyao Zazhi 34:3173-3175
24. Louboutin JP, Agrawal L, Reyes BAS, Van Bockstaele EJ, Strayer DS (2007) Protecting neurons from HIV-1 gp120-induced oxidant stressusing both localized intracerebral and generalized intraventricularadministration of antioxidant enzymes delivered by SV40-derivedvectors. Gene Ther 14:1650-1661
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurementwith the Folin phenol reagent. J Biol Chem 193:265-275
26. Maher P, Akaishi T, Schubert D, Abe K (2010) A pyrazole derivative ofcurcumin enhances memory. Neurobiol Aging 31:706-709
27. Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayon C, Cuadrado A, Lubrini G, Cambron I, Munoz A, Cebolla S, Gutierrez-Fernandez M, Bernardino JI, Arribas JR, Fiala M (2011) HIV-1neuropathogenesis: therapeutic strategies against neuronal loss inducedby gp120/Tat glycoprotein in the central nervous system. RevNeurol 52:101-111
28. Morgan E, Woods S, Smith C, Weber E, Scott JC, Grant I (2012) Lowercognitive reserve among individuals with syndromic HIV-associatedneurocognitive disorders (HAND). AIDS Behav 16:2279-2285
29. No author (1996) Clinical development plan: curcumin. J Cell BiochemSuppl 26:72-85
30. Purohit V, Rapaka R, Rutter J (2014) Cannabinoid receptor-2 andHIV-associated neurocognitive disorders. J Neuroimmune Pharmacol9:447-453
31. Qureshi S, Shah AH, Ageel AM (1992) Toxicity studies on Alpinia galangaand Curcuma longa. Planta Med 58:124-127
32. Samuelsson K, Pirskanen-Matell R, Bremmer S, Hindmarsh T, Nilsson BY, Persson HE (2006) The nervous system in early HIV infection: aprospective study through 7 years. Eur J Neurol 13:283-291
33. Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studiesin rats, guineapigs & monkeys. Indian J Exp Biol 18:73-75
34. Silverstein PS, Shah A, Weemhoff J, Kumar S, Singh DP, Kumar A (2012) HIV-1 gp120 and drugs of abuse: interactions in the central nervoussystem. Curr HIV Res 10:369-383
35. Tang H, Lu D, Pan R, Qin X, Xiong H, Dong J (2009) Curcumin improvesspatial memory impairment induced by human immunodeficiencyvirus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci 85:1-10
36. Trevillyan JM, Mahony AA, McLean C, Hoy JF (2013) Successful treatmentof Epstein-Barr virus encephalitis in the setting of HIV-associatedneurocognitive disorder: a diagnostic and therapeutic challenge.Antivir Ther 18:257-261
37. Vassallo M, Durant J, Biscay V, Lebrun-Frenay C, Dunais B, Laffon M, Harvey-Langton A, Cottalorda J, Ticchioni M, Carsenti H, Pradier C, Dellamonica P (2014) Can high central nervous system penetratingantiretroviral regimens protect against the onset of HIV-associatedneurocognitive disorders? AIDS 28:493-501.
38. von Giesen HJ, Haslinger BA, Rohe S, Köller H, Arendt G (2005) HIV Dementia Scale and psychomotor slowing--the best methods inscreening for neuro-AIDS. J Neuropsychiatry Clin Neurosci 17:185-191
39. Xie L, Li X-K, Takahara S (2011) Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immuno pharmacol 11:323-330
40. Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE (2000) HIV-1 infected mononuclear phagocyte secretory productsaffect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol 6 Suppl 1:14-23
41. Xu K, Li Y (2014) Research progress in neuroprotection of curcuminon Alzheimer’s disease. Linchuang yu Bingli Zazhi 34:93-98
42. Zhao LN, Yu XJ, Han TY, Zhang WM (2012) Research progress on neuroprotectiveeffects of curcumin. Shenjing Yaoli Xuebao 2:58-64
43. Zhao Y, Han XM, Zhao M, Sun YH, Zhu XY, Zhang DZ (2014) Protectionof curcumin against tumor necrotic factor-alpha-mediatedinflammatory injury of vascular endothelial cells. Zhongguo ZuzhiGongcheng Yanjiu 18:6165-6171.